Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management and treatment optimization of patients with mild to moderate ulcerative colitis
Ferdinando D’Amico, Ernesto Fasulo, Vipul Jairath, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 277-290
Closed Access | Times Cited: 17

Showing 17 citing articles:

Formulation, Optimization, and Evaluation of Lornoxicam-Loaded Novasomes for Targeted Ulcerative Colitis Therapy: In Vitro and In Vivo Investigations
Asmaa Badawy Darwish, Abeer Salama, Inas Essam Ibrahim Al-Samadi
Journal of drug targeting (2025), pp. 1-21
Closed Access | Times Cited: 3
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 761-787
Open Access | Times Cited: 7
Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations
Rudra Narayan Subudhi, Neelam Poonia, Dilpreet Singh, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Biobetters and biosimilars in Inflammatory Bowel Disease
Jacopo Fanizza, Ilaria Faggiani, Mariangela Allocca, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101992-101992
Closed Access
Defense mechanisms and inflammatory bowel diseases: a narrative review
Orlando Silvestro, Carmelo M. Vicario, Luis Felipe Costa, et al.
Research in Psychotherapy Psychopathology Process and Outcome (2025)
Open Access
Exploring the Anti-Inflammatory Effect of Tryptanthrin by Regulating TLR4/MyD88/ROS/NF-κB, JAK/STAT3, and Keap1/Nrf2 Signaling Pathways
Jie Zhu, Wen Cheng, Tiantian He, et al.
ACS Omega (2024) Vol. 9, Iss. 28, pp. 30904-30918
Open Access | Times Cited: 2
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study
Silvio Danese, Gionata Fiorino, Éric Vicaut, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5147-5147
Open Access | Times Cited: 2
Influence of Generative AI on Healthcare Industries Enhanced by the Metaverse
Rashmi Kumari, Raghwendra Kishore Singh
Advances in medical technologies and clinical practice book series (2024), pp. 129-166
Closed Access | Times Cited: 1
Colon-targeted self-assembled nanoparticles loaded with berberine double salt ameliorate ulcerative colitis by improving intestinal mucosal barrier and gut microbiota
Yalong Wang, Yan Chen, Hongjuan Zhang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114353-114353
Closed Access | Times Cited: 1
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance
Ernesto Fasulo, Ferdinando D’Amico, Alessandra Zilli, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 60-60
Open Access | Times Cited: 1
SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice
Fei Yang, Minjie Zhang, Ruyi Xu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112234-112234
Closed Access
Inhibition of Wnt/β-catenin Signaling Pathway via XAV939 does not mitigate Dextran Sulfate Sodium-Induced Ulcerative Colitis Running Title: XAV939 does not mitigate Ulcerative Colitis
Shaojie Liang, Kun Wang, Da-bin Mao, et al.
Research Square (Research Square) (2024)
Open Access
Efficacy and safety of Xileisan combined with mesalazine for ulcerative colitis: A meta-analysis and trial sequential analysis
Xinyu Yang, Yunfeng Yu, Ke-Ke Tong, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 21, pp. 4703-4716
Closed Access
Nanocarriers for therapeutic phytochemicals
Mehtap Civelek, Iwona Cicha, Helmut Spielvogel, et al.
Nanomedicine (2024), pp. 1-6
Closed Access
Enhancing ulcerative colitis treatment with traditional Chinese medicine
Wen‐Rui Hao, Chun-Yao Cheng, Tzu-Hurng Cheng
World Journal of Clinical Cases (2024) Vol. 12, Iss. 30, pp. 6358-6360
Closed Access
Melatonin supplementation in preclinical colitis models: A systematic review and dose-response meta-analysis on inflammation, oxidative stress, and colon repair
Yahya Asemani, Reza Heidari, Fatemeh Ezzatifar, et al.
PharmaNutrition (2024) Vol. 30, pp. 100414-100414
Closed Access
Revealing therapeutic targets and drugs from Chinese medicine for ulcerative colitis using bioinformatics
Feng Xu, Xiaofen Li, Xiangpei Wang, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-11
Closed Access
Page 1

Scroll to top